BCLI   $2.25  -7.41% Market Closed After Close 2.25 0.0

Brainstorm Cell Therapeutics Inc
Total Cash 3.47M
totalCashPerShare 0.653
EBITDA -16.04M
Total Debt 962.00K
quickRatio 0.455
currentRatio 0.496
Total Revenue
debtToEquity
Revenue/Share
ROA -1.78204
ROE
grossProfits
freeCashflow -8.45M
operatingCashflow -14.44M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 8.76M
forwardPE -0.6424242
floatShares 4.27M
sharesOutstanding 5.32M
sharesShort 124.59K
sharesShortPriorMonth 85.78K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.15%
Short Ratio help_outline 5.98%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue -0.664
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -12.75M
trailingEps -3.30%
forwardEps -3.30%
enterpriseToEbitda -0.55
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.52 3Q 2024
institutionsCount 50
lastUpdated Oct. 16, 2024, 12:34 p.m.